K Number
K203277
Device Name
Electrosurgical Generator ESG-410, Foot Switches, PK Cutting Forceps
Date Cleared
2021-04-28

(173 days)

Product Code
Regulation Number
878.4400
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
ESG-410: The electrosurgical generator, in conjunction with electrosurgical accessories and ancillary equipment, is intended for cutting and coagulation of tissue in the following medical fields: - Open surgery - Laparoscopic surgery - Endoscopic surgery Only for use by a qualified physician in an adequate medical environment. PK Cutting Forceps (CF-PK0533): The PK Cutting Forceps are indicated for electrosurgical coagulation, mechanical cutting, and grasping of tissue during the performance of laparoscopic and open general surgical procedures.
Device Description
ESG-410 Generator: The subject device ESG-410 is a reusable, non-sterile electrosurgical generator that features different mono- and bipolar cutting and coagulation modes. The maximum output power is 320 W. The front panel of the proposed ESG-410 features a touch screen GUI (graphical user interface) that displays the connection status of accessories and peripherals connected to the electrosurgical generator. Soft keys are integrated into the GUI to switch between the output sockets, to enter the Menu in order to edit settings/ procedures (e.g. create/ edit user-defined settings/ procedures), to edit preferences (e.g. select language, touch tone control, output volume, or brightness) and to show service options (e.g. software version identifier, for service and maintenance purposes) or to assess user-defined settings and procedures. PK Cutting Forceps: The PK Cutting Forceps are a bipolar electrosurgical device that may be utilized in laparoscopic and open general surgery to grasp, coagulate, transect, dissect and retract tissue. The PK Cutting Forceps were cleared via K142759. They are currently intended to be used only with the existing ESG-400 generator per the Indications for Use statement. This submission will demonstrate compatibility with the new ESG-410 generator, and the Indications for Use statement will remove a specific generator model and the compatible generators will be reflected in the labeling. Minor modifications, which did not affect safety and effectiveness, were assessed via internal documentation since the original clearance and will be identified within the submission.
More Information

No
The description focuses on standard electrosurgical generator and forceps technology, with no mention of AI or ML capabilities. The GUI is described as a standard interface for controlling settings, not for intelligent processing.

Yes
The device is described as an "electrosurgical generator" and "PK Cutting Forceps" intended for "cutting and coagulation of tissue," "electrosurgical coagulation, mechanical cutting, and grasping of tissue" during surgical procedures, which are therapeutic actions.

No

The device is an electrosurgical generator and cutting forceps, intended for cutting and coagulation of tissue, not for diagnosing conditions.

No

The device description clearly states that the ESG-410 is a "reusable, non-sterile electrosurgical generator" and the PK Cutting Forceps are a "bipolar electrosurgical device." These are hardware components that perform the primary function of the medical device (cutting and coagulation of tissue). While the generator has a touch screen GUI and software for control and settings, the core functionality is delivered through the hardware.

Based on the provided text, neither the ESG-410 electrosurgical generator nor the PK Cutting Forceps are IVD (In Vitro Diagnostic) devices.

Here's why:

  • Intended Use: The intended use for both devices is for cutting and coagulation of tissue within the body during surgical procedures (open, laparoscopic, and endoscopic). IVD devices are intended for the examination of specimens derived from the human body in vitro (outside the body) to provide information for diagnostic, monitoring, or compatibility purposes.
  • Device Description: The descriptions detail devices used for applying electrical energy directly to tissue for surgical purposes. This is not the function of an IVD device.
  • Lack of IVD Characteristics: The text does not mention any of the typical characteristics of an IVD device, such as:
    • Analyzing biological samples (blood, urine, tissue samples, etc.)
    • Reagents or assays
    • Providing diagnostic information based on laboratory analysis

Therefore, these devices are not IVD devices. They are electrosurgical devices used for therapeutic purposes during surgery.

N/A

Intended Use / Indications for Use

ESG-410:
The electrosurgical generator, in conjunction with electrosurgical accessories and ancillary equipment, is intended for cutting and coagulation of tissue in the following medical fields:

  • · Open surgery
  • Laparoscopic surgery
  • · Endoscopic surgery

Only for use by a qualified physician in an adequate medical environment.

PK Cutting Forceps:
The PK Cutting Forceps are indicated for electrosurgical coagulation, mechanical cutting, and grasping of tissue during the performance of laparoscopic and open general surgical procedures.

Product codes (comma separated list FDA assigned to the subject device)

GEI

Device Description

ESG-410 Generator:
The subject device ESG-410 is a reusable, non-sterile electrosurgical generator that features different mono- and bipolar cutting and coagulation modes. The maximum output power is 320 W.
The front panel of the proposed ESG-410 features a touch screen GUI (graphical user interface) that displays the connection status of accessories and peripherals connected to the electrosurgical generator.
The front panel of the proposed ESG-410 features a touch screen GUI (graphical user interface) that displays the current settings of the chosen output mode, the connection status of accessories and peripherals connected to the electrosurgical generator. Soft keys are integrated into the GUI to switch between the output sockets, to enter the Menu in order to edit settings/ procedures (e.g. create/ edit user-defined settings/ procedures), to edit preferences (e.g. select language, touch tone control, output volume, or brightness) and to show service options (e.g. software version identifier, for service and maintenance purposes) or to assess user-defined settings and procedures.
It is compliant with FDA recognized consensus safety standards as listed in section 2.8.8 below.

PK Cutting Forceps:
The PK Cutting Forceps are a bipolar electrosurgical device that may be utilized in laparoscopic and open general surgery to grasp, coagulate, transect, dissect and retract tissue. The PK Cutting Forceps were cleared via K142759. They are currently intended to be used only with the existing ESG-400 generator per the Indications for Use statement. This submission will demonstrate compatibility with the new ESG-410 generator, and the Indications for Use statement will remove a specific generator model and the compatible generators will be reflected in the labeling. Minor modifications, which did not affect safety and effectiveness, were assessed via internal documentation since the original clearance and will be identified within the submission.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Only for use by a qualified physician in an adequate medical environment.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance Testing Bench:
ESG-410 Electrosurgical Generator
To demonstrate substantial equivalence following aspects were considered within the validation versus the predicate devices.

  1. Performance and validation tests incorporated the same range of waveform outputs and power levels.
  2. During the validation testing the waveforms and tissue effects were compared directly between the subjected and predicate device and between the subject and reference devices.

Bench testing supports the claim of substantial equivalence to the predicate devices. The validation plan specifies modes, instruments and test protocols/plans for tissue effects and electrical waveforms. Beside tissue effects, the waveforms of the generators were compared. For all modes the tests demonstrated comparable tissue effects and electrically comparable waveforms.

The following non-clinical and preclinical tests were conducted:

  1. non-clinical (electrical, dimensional, functional, stability)
  2. preclinical (simulated use) evaluation and testing of tissue effects and thermal safety

Non-clinical: Basic safety and performance testing was performed in accordance with IEC standards. In addition, verification and comparison bench studies were conducted to evaluate the functional performance.

Preclinical: Evidence obtained from preclinical simulated use studies demonstrate that the device performs substantially equivalent to the predicate device in relevant aspects associated with usability, tissue effects, and thermal effects. For simulated use testing, three clinically relevant tissue types were evaluated in all applicable modes. The tissue effects testing included quantitative and qualitative assessment.

These comprehensive validation bench tests support equivalence to the predicate device. Testing confirmed that comparable tissue effects could be achieved for applicable modes of operation with three tissue types.

Usability and user interface was also assessed according to the risk management plan. The assessment was based on Olympus predecessor product. Use-related hazardous situations were assessed and risk mitigation measures in terms of usability design for safety were defined. The residual risk was evaluated as acceptable.

Risk analysis was carried out in accordance with established internal acceptance criteria based on ISO 14971:2007.

PK Cutting Forceps ( PK-CF0533)
Basic compatibility testing was conducted to confirm compatibility of the legacy PK Cutting Forceps with the subject ESG-410 generator. "ACTIVE ACCESSORY HF Dielectric Strength" testing per IEC 60601-2-2:2017 Ed.6, Clause 201.8.8.3.103 and "Maximum Temperature During Normal Use" testing per IEC 60601-2-2:2017 Ed.6, Clause 201.11.1.1 were repeated for the PK Cutting Forceps with the ESG-410 generator as part of the basic compatibility testing to demonstrate compatibility with the new generator.

Conclusion:
The performance data support the safety of the devices and demonstrate that the subject devices comply with the recognized standards as specified.
In summary, we believe the ESG-410 and accessories are substantially equivalent with the predicate devices with respect to the general design approach, function, and the intended use. The subject ESG-410 and the compatibility of the PK Cutting Forceps with the subject ESG-410, raise no new concerns of safety or effectiveness when compared to the predicate and the reference devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K141225, K142759

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

K151649, K060484

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.4400 Electrosurgical cutting and coagulation device and accessories.

(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

April 28, 2021

Olympus Winter & Ibe GmbH % Christina Flores Regulatory Affairs Manager Olympus Surgical Technologies America 118 Turnpike Road Southborough, Massachusetts 01772

Re: K203277

Trade/Device Name: Electrosurgical Generator ESG-410, Foot Switches, PK Cutting Forceps Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical Cutting and Coagulation Device and Accessories Regulatory Class: Class II Product Code: GEI Dated: March 29, 2021 Received: March 30, 2021

Dear Christina Flores:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies.combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

1

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531 -542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.

510(k) Number (if known)

K203277

Device Name Electrosurgical Generator ESG-410 and Accessories

Indications for Use (Describe)

ESG-410:

The electrosurgical generator, in conjunction with electrosurgical accessories and ancillary equipment, is intended for cutting and coagulation of tissue in the following medical fields:

  • · Open surgery
    · Laparoscopic surgery

· Endoscopic surgery

Only for use by a qualified physician in an adequate medical environment.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Form Approved: OMB No. 0910-0120

Expiration Date: 06/30/2020

See PRA Statement below.

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

510(k) Number (if known)

K203277

Device Name PK Cutting Forceps (CF-PK0533)

Indications for Use (Describe)

The PK Cutting Forceps are indicated for electrosurgical coagulation, mechanical cutting, and grasping of tissue during the performance of laparoscopic and open general surgical procedures.

Type of Use (Select one or both, as applicable)> Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

4


2 510(k) Summary of Safety and Effectiveness

2.1 General Information

| Applicant is: | Olympus Winter & Ibe GmbH
Kuehnstrasse 61
22045 Hamburg
Germany
Establishment Registration Number: 9610773 |
|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer: | Olympus Winter & Ibe GmbH
Berlin Facility
Rheinstrasse 8
14513 Teltow
Germany
Establishment Registration Number: 3003724334 |
| Contract Manufacturer: | STEUTE TECHNOLOGIES GMBH & CO. KG
Brueckenstrasse 91
32584 Loehne Nordrhein-Westfalen
Germany
Establishment Registration Number: 3015515531 |
| 510(k) Correspondent: | Christina Flores, RAC
Manager, Regulatory Affairs
Olympus Surgical Technologies America
118 Turnpike Road
Southborough, MA 01772
Phone:
508-808-3341
Email: christina.flores@olympus.com
Establishment Registration Number: 3003790304 |
| Date prepared: | November 5, 2020 |

2.2 Device Identification

| Device name and models: | Electrosurgical Generator ESG-410 and Accessories, and
PK Cutting Forceps (PK-CF0553) |
|-------------------------|------------------------------------------------------------------------------------------|
| Common name: | Electrosurgical Generator and Accessories,
Electrosurgical devices |

5

Classification Number:21 CFR 878.4400
Classification name:Electrosurgical cutting and coagulation device and
accessories
Product code:GEI
Product code name:Electrosurgical, Cutting & Coagulation Accessories
Regulatory class:Class II
Review Panel:General & Plastic Surgery

2.3 Predicate Device

The ESG-410 and accessories are considered substantially equivalent to the following legally marketed devices:

Predicate DeviceManufacturer510(k) No
ESG-400Olympus Winter & Ibe GmbHK141225
PK Cutting ForcepsOlympus Surgical Technologies
AmericaK142759

Table 2.1: Identification of predicate device

The following reference devices for the ESG-410 for particular monopolar and/or bipolar cutting and/or coagulation modes only have been chosen for substantial equivalence discussion in terms of safety and effectiveness.

Reference devicesManufacturer510(k) No
Valleylab™ FT10 Energy PlatformCovidienK151649
VIO ESU (Model VIO 300D)Erbe USA, Inc.K060484

Table 2.2: Reference devices for a few specific features

2.4 Product Description

ESG-410 Generator

The subject device ESG-410 is a reusable, non-sterile electrosurgical generator that features different mono- and bipolar cutting and coagulation modes. The maximum output power is 320 W.

The front panel of the proposed ESG-410 features a touch screen GUI (graphical user interface) that displays the connection status of accessories and peripherals connected to the electrosurgical generator.

The front panel of the proposed ESG-410 features a touch screen GUI (graphical user interface) that displays the current settings of the chosen output mode, the connection

6

status of accessories and peripherals connected to the electrosurgical generator. Soft keys are integrated into the GUI to switch between the output sockets, to enter the Menu in order to edit settings/ procedures (e.g. create/ edit user-defined settings/ procedures), to edit preferences (e.g. select language, touch tone control, output volume, or brightness) and to show service options (e.g. software version identifier, for service and maintenance purposes) or to assess user-defined settings and procedures.

It is compliant with FDA recognized consensus safety standards as listed in section 2.8.8 below.

PK Cutting Forceps

The PK Cutting Forceps are a bipolar electrosurgical device that may be utilized in laparoscopic and open general surgery to grasp, coagulate, transect, dissect and retract tissue. The PK Cutting Forceps were cleared via K142759. They are currently intended to be used only with the existing ESG-400 generator per the Indications for Use statement. This submission will demonstrate compatibility with the new ESG-410 generator, and the Indications for Use statement will remove a specific generator model and the compatible generators will be reflected in the labeling. Minor modifications, which did not affect safety and effectiveness, were assessed via internal documentation since the original clearance and will be identified within the submission.

2.5 Indications for Use

ESG-410 Electrosurgical Generator

The electrosurgical generator. in conjunction with electrosurgical accessories and ancillary equipment, is intended for cutting and coagulation of tissue in the following medical fields:

  • . Open surgery
  • Laparoscopic surgery .
  • . Endoscopic surgery

Only for use by a qualified physician in an adequate medical environment.

PK Cutting Forceps

The PK Cutting Forceps are indicated for electrosurgical coagulation, mechanical cutting, and grasping of tissue during the performance of laparoscopic and open surgical procedures.

2.6 Technological Characteristics

The subject ESG-410 has the same intended use and technological characteristics as the predicate device ESG-400.

Various instruments can be connected to the two monopolar sockets or one bipolar socket as well as to the two universal sockets. In addition, dedicated Olympus

7

instruments or Olympus cables can be connected to the two universal sockets with instrument recognition.

The basic design philosophy of the User Interface (UI) and GUI flow chart concept is equivalent. Compared to the ESG-400, the ESG-410 offers additional output modes.

There have been no changes to the intended use or technological characteristics of the PK Cutting Forceps, since its clearance in K142759.

Output modes in comparison to the predicate device ESG-400 2.6.1

In comparison to the predicate device the following output modes are available:

Subject Device:Predicate Device:
ESG-410ESG-400 (K141225)
PureCutPureCut
BlendCutBlendCut
PulseCut FastPulseCut Fast
PulseCut SlowPulseCut Slow
FineCutFineCut
PowerCutPowerCoag

Table 2.3: Monopolar Cut Modes

Subject Device:Predicate Device:
ESG-410ESG-400 (K141225)
SpraySprayCoag (Effect 3)
SprayCoagSprayCoag
PowerCoagPowerCoag
ForcedCoagForcedCoag

Table 2.4: Monopolar Coagulation Modes

Subject Device:Predicate Device:
ESG-410ESG-400 (K141225)
BipolarCutBipolarCut
PlasmaCutSalineCut
PK LoopCutPK LoopCut
PK MorceCutPK MorceCut
PK PureCutPK PureCut
PK SoftCutPK SoftCut

Table 2.5: Bipolar Cut Modes

Subject Device:Predicate Device:
ESG-410ESG-400 (K141225)
BiSoftCoagBiSoftCoag
AutoCoagAutoCoag
HardCoagHardCoag
SalineCoagSalineCoag
PK SoftCoagPK SoftCoag
PK CoagPK Coag
N/ARFCoag (w/o RCAP)
N/ARFCoag (w/ RCAP)

8

Subject Device:Predicate Device:
ESG-410ESG-400 (K141225)
N/AFineCoag
N/APK AutoCoag

Table 2.6: Bipolar Coagulation Modes

The range of output waveforms and the power levels are identical in comparison to the FDA cleared ESG-400 electrosurgical generator, K141225.

Output modes in comparison to the reference devices 2.6.2

As stated above, the reference devices are solely used for specific additional monopolar tissue cutting and coagulation modes that are comparable in the subject device and reference device.

2.6.2.1 COVIDIEN ValleylabTM FT10 Energy Platform

The reference device COVIDIEN Valleylab TM FT10 Energy Platform is provided for implementation of monopolar cutting and for monopolar coagulation modes that are not presented in the predicate device, the ESG-400.

| Subject Device:
ESG-410 | Reference Device
COVIDIEN ValleylabTM FT10 Energy
Platform (K151649) |
|----------------------------|----------------------------------------------------------------------------|
| Pure | Pure |
| Blend | Blend |

Table 2.7: Monopolar Cut Modes - Reference Device - COVIDIEN Valleylab™ FT10 Energy Platform

Subject Device:Reference Device
ESG-410COVIDIEN ValleylabTM FT10 Energy
Platform (K151649)
FulgurateFulgurate

Table 2.8: Monopolar Coagulation Modes - Reference Device - COVIDIEN Valleylab™ FT10 Energy Platform

The range of output waveforms and the power levels are equivalent in comparison to the FDA cleared COVIDIEN ValleylabTM FT10 Energy Platform, K151649.

2.6.2.2 ERBE VIO ESU (Model VIO 300D)

The reference device ERBE VIO ESU (Model VIO 300D) is provided for implementation of the monopolar coagulation mode SoftCoag, that is not presented in the predicate device, the ESG-400.

| Subject Device:
ESG-410 | Reference Device
ERBE VIO ESU (Model VIO 300D)
(K060484) |
|----------------------------|----------------------------------------------------------------|
| SoftCoag | Soft Coag |

Table 2.9: Monopolar Coagulation Mode - Reference Device - ERBE VIO ESU (Model VIO 300D)

9

The range of output waveforms and the power levels are equivalent in comparison to the FDA cleared ERBE VIO ESU (Model VIO 300D), K060484.

2.7 Substantial Equivalence

Substantial equivalence is demonstrated by acknowledged verification/validation methodologies. The subject devices have equivalent technology, performance, dimensions and materials. The differences to the predicate device ESG-400 are:

  • o Two identical monopolar output sockets in the ESG-410, compared to two various monopolar (E-type and B-type) output sockets in the predicate device
  • o Two universal output sockets in the ESG-410. compared to one universal output socket in the predicate device
  • no docking station interface on the bottom in the ESG-410 .
  • . Three foot switch sockets, all suitable for double pedal wired and wireless and for single pedal wired in the ESG-410, compared to two foot switch socket, both suitable for double pedal and single pedal
  • The COM indicator is integrated into the touch screen of the ESG-410, in the . predicate device the CQM indicator is placed below the lower monopolar output socket
  • . The touch screen of the ESG-410 is approximately one third larger compared to the size of the predicate device.
  • Three soft buttons for 'Settings', 'Procedure', 'Foot switch' and one Info . button for the 'COM' are integrated in the home screen of the ESG-410 compared to three buttons that were integrated into the touch screen of the predicate device
  • The ESG-410 has one additional ventilation slot on the rear panel. .
  • . The ESG-410 provides 28 ventilation slots on the side panels, compared to 32 ventilation slots provided by the predicate device
  • The ESG-410 provides an USB-socket for storage, import and export of user-. defined procedures on a portable USB flash drive. The USB-socket is not provided in the ESG-400

Regarding the additionally implemented monopolar cutting and coagulation modes two reference devices have been chosen, because of their specific output modes. For those two reference devices, the substantial equivalence is demonstrated by acknowledged verification/ validation methodologies. The subject devices have equivalent technology and performance in respect to the compared modes.

The previously cleared PK Cutting Forceps (K142759) are included in this submission to demonstrate compatibility with the subject ESG-410 generator and to update the labeling. There have been no changes to the technological characteristics or intended use of the device since its original clearance. The basic compatibility testing and limited electrical testing demonstrate substantial equivalence to the originally cleared PK Cutting Forceps.

10

2.8 Performance Data

The following performance data were provided in support of the substantial equivalence determination. All standards applied are FDA recognized international standards.

All data was prepared in accordance with the FDA guidance, "Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery" Guidance for Industry and Food and Drug Administration Staff, issued on March 9, 2020. The guidance was followed for all relevant sections.

2.8.1 Biocompatibility testing

The ESG-410 and its accessories do not contain components that come directly or indirectly in patient contact. Biocompatibility testing according to ISO 10993 is not required.

Biocompatibility evaluation of the previously cleared PK Cutting Forceps (PK-CF0533) was successfully established in K142759 according to ISO 10993-1 Biological Evaluation of Medical Devices-Part 1: Evaluation and Testing. There have been no changes to the device that affect the biocompatibility established in K142759.

Electrical safety and electromagnetic compatibility (EMC) 2.8.2

The design of the ESG-410 complies with recognized standards as listed in section 2.8.8.

The FDA guidance "Information to Support a Claim of Electromagnetic Compatibility (EMC) of Electrically-Powered Medical Devices", CDRH July 11, 2016 has been followed.

There have been no changes to the PK Cutting Forceps since the original clearance that affect electrical safety or electromagnetic compatibility. However, "ACTIVE ACCESSORY HF Dielectric Strength" testing per IEC 60601-2-2:2017 Ed.6, Clause 201.8.8.3.103 and "Maximum Temperature During Normal Use" testing per IEC 60601-2-2:2017 Ed.6, Clause 201.11.1.1 were repeated for the PK Cutting Forceps with the ESG-410 generator. This testing was part of the basic compatibility testing to demonstrate compatibility of the PK Cutting Forceps with the subject ESG-410 generator.

2.8.3 Thermal Safety

The design of the ESG-410 complies with recognized standards as listed in section 2.8.8.

2.8.4 Clinical and animal Studies

Clinical and animal studies were not necessary.

11

2.8.5 Software

The subject ESG-410 generator contains software. The software validation activities were performed in accordance with the FDA Guidance. "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" (May 11, 2005). The device software is considered a "Major Level of Concern".

The previously cleared PK Cutting Forceps (K147259) do not contain software.

2.8.6 Performance Testing Bench

ESG-410 Electrosurgical Generator

To demonstrate substantial equivalence following aspects were considered within the validation versus the predicate devices.

    1. Performance and validation tests incorporated the same range of waveform outputs and power levels.
    1. During the validation testing the waveforms and tissue effects were compared directly between the subjected and predicate device and between the subject and reference devices.

Bench testing supports the claim of substantial equivalence to the predicate devices. The validation plan specifies modes, instruments and test protocols/plans for tissue effects and electrical waveforms. Beside tissue effects, the waveforms of the generators were compared. For all modes the tests demonstrated comparable tissue effects and electrically comparable waveforms.

The following non-clinical and preclinical tests were conducted:

    1. non-clinical (electrical, dimensional, functional, stability)
    1. preclinical (simulated use) evaluation and testing of tissue effects and thermal safety

Non-clinical: Basic safety and performance testing was performed in accordance with IEC standards. In addition, verification and comparison bench studies were conducted to evaluate the functional performance.

Preclinical: Evidence obtained from preclinical simulated use studies demonstrate that the device performs substantially equivalent to the predicate device in relevant aspects associated with usability, tissue effects, and thermal effects. For simulated use testing, three clinically relevant tissue types were evaluated in all applicable modes. The tissue effects testing included quantitative and qualitative assessment.

These comprehensive validation bench tests support equivalence to the predicate device. Testing confirmed that comparable tissue effects could be achieved for applicable modes of operation with three tissue types.

12

Usability and user interface was also assessed according to the risk management plan. The assessment was based on Olympus predecessor product. Use-related hazardous situations were assessed and risk mitigation measures in terms of usability design for safety were defined. The residual risk was evaluated as acceptable.

Risk analysis was carried out in accordance with established internal acceptance criteria based on ISO 14971:2007.

PK Cutting Forceps ( PK-CF0533)

Basic compatibility testing was conducted to confirm compatibility of the legacy PK Cutting Forceps with the subject ESG-410 generator. "ACTIVE ACCESSORY HF Dielectric Strength" testing per IEC 60601-2-2:2017 Ed.6, Clause 201.8.8.3.103 and "Maximum Temperature During Normal Use" testing per IEC 60601-2-2:2017 Ed.6, Clause 201.11.1.1 were repeated for the PK Cutting Forceps with the ESG-410 generator as part of the basic compatibility testing to demonstrate compatibility with the new generator.

2.8.7 Reprocessing

Required cleaning, disinfecting and drying procedures are described in the instructions for use.

The PK Cutting Forceps are provided sterile, for single-use. They are not intended to be reprocessed.

13

2.8.8 Applied standards

| Standard No. | Standard Title | FDA-Recognition
no + date |
|-------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------|
| AAMI/ANSI ES
60601-1:2005/(R)2012
and C1:2009/(R)2012
and, A2:2010/(R)2012 | Medical electrical equipment - Part 1: General
requirements for basic safety and essential performance
(IEC 60601-1:2005, MOD) | 19-4
07/09/2014 |
| IEC
60601-1-2
Ed. 4.0:
2014 | Medical electrical equipment - Part 1-2: General
requirements for basic safety and essential performance -
Collateral Standard: Electromagnetic disturbances -
Requirements and tests | 19-8
09/17/2018 |
| IEC
60601-1-8
Ed. 2.1:
2012 | Medical electrical equipment - Part 1-8: General
requirements for basic safety and essential performance -
Collateral Standard: General requirements, tests and
guidance for alarm systems in medical electrical
equipment and medical electrical systems | 5-76
08/06/2013 |
| IEC
60601-2-2
Ed. 6.0:
2017 | Medical electrical equipment - Part 2-2: Particular
requirements for the basic safety and essential
performance of high frequency surgical equipment and
high frequency surgical accessories | 6-389
08/21/2017 |
| IEC
62304
Ed. 1.1
2015
consolidated version | Medical device software - Software life cycle processes | 13-79
01/14/2019 |
| IEC
60601-1-6
Ed. 3.1:
2013 | Medical electrical equipment Part 1-6: General
requirements for basic safety and essential performance -
Collateral standard: Usability | 5-89
06/27/2016 |
| IEC 62366-1
Edition 1.0
2015 | Medical devices - Part 1: Application of usability
engineering to medical devices [Including
CORRIGENDUM 1 (2016)] | 5-114
12/23/2016 |
| ISO 14971 second
edition 2007 | Medical devices - Application of risk management to
medical devices | 5-40
06/27/2016 |

Table 2.10: Applied standards

2.9 Conclusion

The performance data support the safety of the devices and demonstrate that the subject devices comply with the recognized standards as specified.

In summary, we believe the ESG-410 and accessories are substantially equivalent with the predicate devices with respect to the general design approach, function, and the intended use. The subject ESG-410 and the compatibility of the PK Cutting Forceps with the subject ESG-410, raise no new concerns of safety or effectiveness when compared to the predicate and the reference devices.